Therapeutic Angiogenesis
- 1 July 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 16 (4) , 163-171
- https://doi.org/10.1097/crd.0b013e3181620e3b
Abstract
Angiogenesis is the biologic process of forming new blood vessels and is being investigated as an innovative therapeutic approach to help manage ischemic heart disease and peripheral vascular disease. Research studies have identified various angiogenic growth factors and progenitor cells that can enhance new blood vessel formation. Preclinical investigations in animal models have explored the potential use of growth factors with and without progenitor cells to treat myocardial ischemia. The results of clinical trials with growth factor infusions and gene therapy techniques to enhance growth factor production have shown some promise, but therapeutic angiogenesis remains at an early stage of development.Keywords
This publication has 56 references indexed in Scilit:
- Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closureBlood, 2007
- Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expressionEuropean Journal of Cell Biology, 2000
- Elevation of Vascular Endothelial Growth Factor-A Serum Levels Following Acute Myocardial Infarction. Evidence for its Origin and Functional SignificanceJournal of Molecular and Cellular Cardiology, 2000
- Stretch-induced VEGF expression in the heart.Journal of Clinical Investigation, 1997
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac PerformanceJournal of Cardiovascular Pharmacology, 1996
- The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic PotencyJournal of Biological Chemistry, 1996
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992